DRKS00032186招募中不适用
Development of a method for secondary and tertiary prevention of head and neck tumors - OncSaliva
niversitätsklinikum Jena, Klinik für Hals-, Nasen- und Ohrenheilkunde0 个研究点目标入组 100 人开始时间: 2023年7月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •- with head and neck tumours
- •- Men and women who come to the scene for the clarification of symptoms with suspicion for malignancy in the head and neck area in the otolaryngology clinic,
- •- Primary tumors and recurrent tumors
- •- HPV-independent (HPV+ and HPV-)
- •- Age = 18 years
- •- Patients without head and neck cancer who have undergone surgery
- •tissue is obtained from the oropharynx, e.g. with recurrent
- •Tonsillitis who present for tonsillectomy
排除标准
- •- Salivary gland malignancies
- •-Lack of consent
研究者
相似试验
已完成
不适用
Development, implementation and evaluation of two tailored based physical activity intervention for the over-fifties.Externe factoren van ziekte en sterftenvtNL-OMON29808niversiteit Maastricht2,000
招募中
不适用
The development of a new method for evaluation of glaucoma (The relationship between ocular circulation and neural activity in glaucoma patients)glaucomaJPRN-UMIN000023960Asahikawa Medical University50
进行中（未招募）
不适用
Entwicklung einer Untersuchungsmethode zur Bestimmung des NO-Transferfaktors der Lunge Evaluierung der Methode und Normwerterhebung an gesunden Probanden(Development of a new method for steady-state measurement of NO lung diffusing capacity in healthy subjects)ung function testing (NO- and CO Transferfactor) in healthy subjectsEUCTR2005-005678-61-DEniversity Hospital Tuebingen107
进行中（未招募）
1 期
An extension to a phase II study to determine the safety and anti-leukemic effects of STI571 in patients with Philadelphia chromosome-positive leukemia including acute lymphoblastic leukaemia, acute myeloid leukaemia, and accelerated phase chronic myeloid leukemia - N/APhiladelphia chromosome-opositive chronic myeloid leukamia in myeloid blast crisisEUCTR2004-001396-19-GBovartis Pharmaceuticals UK Ltd293
进行中（未招募）
不适用
An extension to a phase II study to determine the safety and the anti- leukemic effects of STI571 in adults patients with Philadelphia chromosome positive leukemia including acute lymphoblastic leukemia, acute myeloid leukemia and accelerate phase myeloid leukemia.Philadelphia chromosome positive leukemia including acute lymphoblastic leukemia, acute myeloid leukemia and accelerate phase myeloid leukemia.MedDRA version: 14.1Level: HLTClassification code 10024296Term: Leukaemias chronic myeloidSystem Organ Class: 100000004851EUCTR2005-001381-14-ITOVARTIS FARMA294